This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Illumina Corporation. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Li Teng
Introduction
Li Teng is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of nucleic acid sequencing, holding 2 patents that enhance the efficiency and accuracy of sequencing techniques. His work is pivotal in advancing genetic research and diagnostics.
Latest Patents
Li Teng's latest patents focus on off-target capture reduction in sequencing techniques. These patents present methods and compositions for enhancing the specific enrichment of target sequences in a nucleic acid library. Off-target hybridization probes are utilized to minimize the binding and capture of off-target regions in a targeted sequencing workflow. These probes are specifically designed for locations known to generate off-target sequencing reads for particular sets of hybridization probes.
Career Highlights
Li Teng is currently employed at Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to groundbreaking advancements in sequencing technologies. His innovative approaches have positioned him as a key figure in the development of more precise and efficient sequencing methods.
Collaborations
Li Teng collaborates with talented individuals in his field, including Chia-Ling Hsieh and Charles Lin. These collaborations foster a creative environment that enhances the development of innovative solutions in nucleic acid sequencing.
Conclusion
Li Teng's contributions to the field of nucleic acid sequencing through his patents and work at Illumina Corporation highlight his role as a significant innovator. His advancements are crucial for the future of genetic research and diagnostics.